Cite
HARVARD Citation
Takeuchi, T. et al. (2019). Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan. Annals of the rheumatic diseases. 78 (10), pp. 1305-1319. [Online].